Total Payments
$31,724
2024 Payments
$2,910
Companies
50
Transactions
734
Medicare Patients
23,740
Medicare Billing
$3.0M
Payment Breakdown by Category
Research$15,800 (49.8%)
Food & Beverage$14,928 (47.1%)
Other$908.12 (2.9%)
Education$88.47 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,800 | 1 | 49.8% |
| Food and Beverage | $14,928 | 721 | 47.1% |
| Honoraria | $700.00 | 2 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208.12 | 5 | 0.7% |
| Education | $88.47 | 5 | 0.3% |
Payments by Type
General
$15,924
733 transactions
Research
$15,800
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $15,800 | 1 | $0 (2023) |
| ABBVIE INC. | $3,632 | 159 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,298 | 56 | $0 (2024) |
| Biofrontera Inc. | $1,022 | 6 | $0 (2024) |
| PFIZER INC. | $872.48 | 73 | $0 (2024) |
| Lilly USA, LLC | $821.08 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $801.13 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $798.24 | 28 | $0 (2024) |
| Galderma Laboratories, L.P. | $634.37 | 24 | $0 (2024) |
| Amgen Inc. | $514.73 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,910 | 109 | E.R. Squibb & Sons, L.L.C. ($676.29) |
| 2023 | $18,436 | 101 | Eli Lilly and Company ($15,800) |
| 2022 | $1,812 | 75 | ABBVIE INC. ($435.02) |
| 2021 | $854.20 | 31 | AbbVie Inc. ($256.54) |
| 2020 | $827.23 | 48 | AbbVie Inc. ($200.76) |
| 2019 | $2,268 | 89 | Biofrontera Inc. ($473.02) |
| 2018 | $2,015 | 126 | AbbVie, Inc. ($379.79) |
| 2017 | $2,601 | 155 | Biofrontera Inc. ($463.63) |
All Payment Transactions
734 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $42.00 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.86 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $121.37 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $33.91 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $99.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PSOSA (PSORIASIS SPECIAL AREAS) - A US-BASED SINGLE-ARM PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF NAIL AND SCALP PSORIASIS IMPROVEMENT IN PATIENTS TREATED WITH IXEKIZUMAB | Eli Lilly and Company | $15,800 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 6,026 | 11,934 | $4.6M | $768,682 |
| 2022 | 32 | 5,973 | 11,700 | $4.6M | $754,369 |
| 2021 | 34 | 6,402 | 12,166 | $4.8M | $832,954 |
| 2020 | 33 | 5,339 | 9,600 | $2.8M | $653,401 |
Total Patients
23,740
Total Services
45,400
Medicare Billing
$3.0M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 240 | 340 | $764,660 | $156,247 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,234 | 1,810 | $537,570 | $102,073 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 704 | 950 | $321,100 | $61,390 | 19.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 112 | 173 | $236,318 | $52,937 | 22.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 960 | 1,480 | $330,040 | $51,220 | 15.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Facility | 2023 | 128 | 173 | $389,077 | $39,915 | 10.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 202 | 237 | $371,616 | $27,289 | 7.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 749 | 4,726 | $108,698 | $22,473 | 20.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 39 | 46 | $97,152 | $20,620 | 21.2% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Facility | 2023 | 30 | 30 | $99,090 | $19,111 | 19.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 120 | 158 | $93,852 | $17,894 | 19.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Facility | 2023 | 46 | 46 | $116,978 | $15,582 | 13.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 46 | 47 | $66,505 | $14,708 | 22.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 216 | 378 | $63,504 | $13,923 | 21.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 168 | 190 | $71,820 | $13,920 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 160 | $67,200 | $13,752 | 20.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 95 | 119 | $66,878 | $13,702 | 20.5% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Facility | 2023 | 23 | 24 | $73,272 | $13,566 | 18.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Facility | 2023 | 55 | 82 | $112,012 | $12,231 | 10.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 22 | 36 | $45,900 | $10,810 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 161 | 161 | $59,409 | $10,568 | 17.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 84 | 98 | $138,670 | $9,667 | 7.0% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Facility | 2023 | 15 | 15 | $49,350 | $9,071 | 18.4% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Facility | 2023 | 19 | 20 | $50,320 | $6,618 | 13.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 20 | 20 | $26,460 | $5,630 | 21.3% |
About Dr. Mark Fleischman, MD
Dr. Mark Fleischman, MD is a Dermatology healthcare provider based in Leawood, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215975867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Fleischman, MD has received a total of $31,724 in payments from pharmaceutical and medical device companies, with $2,910 received in 2024. These payments were reported across 734 transactions from 50 companies. The most common payment nature is "" ($15,800).
As a Medicare-enrolled provider, Fleischman has provided services to 23,740 Medicare beneficiaries, totaling 45,400 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, MOHS-Micrographic Surgery
- Location Leawood, KS
- Active Since 06/04/2006
- Last Updated 08/04/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1215975867
Products in Payments
- TALTZ (Drug) $16,399
- RINVOQ (Biological) $1,031
- Ameluz (Drug) $1,011
- SKYRIZI (Biological) $851.88
- COSENTYX (Biological) $772.10
- Humira (Biological) $747.28
- Sotyktu (Drug) $688.93
- DUPIXENT (Biological) $650.31
- Otezla (Drug) $619.11
- EUCRISA (Drug) $527.74
- COSENTYX (Drug) $438.90
- ILUMYA (Biological) $291.68
- REMICADE (Biological) $282.23
- OPZELURA (Drug) $274.19
- Zoryve (Drug) $256.61
- HUMIRA (Biological) $253.61
- ELZONRIS (Drug) $221.42
- ADBRY (Biological) $196.85
- Cimzia (Drug) $173.75
- DORYX (Drug) $167.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Leawood
Kyle Anderson, Md, MD
Dermatology — Payments: $22,805
Dermatology $22,805
Celeste Angel, Do, DO
Dermatology — Payments: $10,086
Dermatology $10,086
Karen Neubauer, Do, DO
Dermatology — Payments: $5,966
Dermatology $5,966
Colin Ruff, Md, MD
Dermatology — Payments: $4,223
Dermatology $4,223
James Allen, Md, MD
Dermatology — Payments: $4,171
Dermatology $4,171
Glenn Goldstein, Md, MD
Dermatology — Payments: $3,781
Dermatology $3,781